These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 7507074
1. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ. Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074 [Abstract] [Full Text] [Related]
2. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA, Muller WJ. Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804 [Abstract] [Full Text] [Related]
4. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Thomas JE, Aguzzi A, Soriano P, Wagner EF, Brugge JS. Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725 [Abstract] [Full Text] [Related]
6. The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members. Webster MA, Martin-Soudant N, Nepveu A, Cardiff RD, Muller WJ. Oncogene; 1998 Apr 16; 16(15):1963-72. PubMed ID: 9591780 [Abstract] [Full Text] [Related]
11. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. Andrechek ER, Muller WJ. Breast Cancer Res; 2000 Mar 16; 2(3):211-6. PubMed ID: 11250712 [Abstract] [Full Text] [Related]
12. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein. Rauh MJ, Blackmore V, Andrechek ER, Tortorice CG, Daly R, Lai VK, Pawson T, Cardiff RD, Siegel PM, Muller WJ. Mol Cell Biol; 1999 Dec 16; 19(12):8169-79. PubMed ID: 10567542 [Abstract] [Full Text] [Related]
13. Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells. Berman-Golan D, Elson A. Oncogene; 2007 Oct 25; 26(49):7028-37. PubMed ID: 17486066 [Abstract] [Full Text] [Related]
14. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Amundadottir LT, Leder P. Oncogene; 1998 Feb 12; 16(6):737-46. PubMed ID: 9488037 [Abstract] [Full Text] [Related]
15. Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells. Granot-Attas S, Elson A. Exp Cell Res; 2004 Mar 10; 294(1):236-43. PubMed ID: 14980517 [Abstract] [Full Text] [Related]
18. Src family kinases are required for integrin but not PDGFR signal transduction. Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P. EMBO J; 1999 May 04; 18(9):2459-71. PubMed ID: 10228160 [Abstract] [Full Text] [Related]
19. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function. Brickell PM. Crit Rev Oncog; 1992 May 04; 3(4):401-46. PubMed ID: 1384720 [Abstract] [Full Text] [Related]
20. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases. Han NM, Curley SA, Gallick GE. Clin Cancer Res; 1996 Aug 04; 2(8):1397-404. PubMed ID: 9816313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]